Novozymes Biopharma has launched Cellprime rTransferrin AF and Cellprime rAlbumin AF-G.
Cellprime rTransferrin AF is an animal-free alternative to serum-derived human or bovine transferrin, for industrial cell culture and upstream biopharmaceutical applications.
It is designed to reduce risk and ease regulatory concerns, as it improves the consistency of batch quality and productivity of customers' industrial cell culture processes.
Manufactured in FDA-inspected facilities to cGMP standards, Cellprime rTransferrin AF is suitable for research and commercial-scale mammalian cell culture.
Cellprime rAlbumin AF-G is an animal-free, recombinant human albumin developed specifically for large-scale industrial cell culture.
It offers multiple benefits, including the maintenance of osmotic balance and transport, and the distribution of fatty acids and amino acids, as well as improving the consistency of customers' industrial cell culture processes.
